FDA.reportPublic FDA data

GABAPENTIN

Product NDC
68071-3445
11-digit product format
680713445
Labeler code
68071
Product ID
68071-3445_2d5a1af5-a987-2e15-e063-6294a90af9b6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Gabapentin
Dosage form
TABLET
Route
ORAL
Labeler
NuCare Pharmaceuticals,Inc.
Application
ANDA214957
Marketing category
ANDA
Marketing start
2021-10-01
Substance
GABAPENTIN
Active strength
600 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
GABAPENTIN
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GABAPENTIN600 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii6CW7F3G59X
Rxcui310433

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cdc2ae60-922e-452d-a42f-787fe4e2ed06Product name120250123
7059096a-4b9f-36c2-db50-bb5c723e6e9eProduct name220250114
fa3f0129-3502-889f-f424-3a37727959e7Product name920181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68071-3445-32025-02-04C16284748780-12cef2736-ae54-d83d-e063-dadaa90ab31fThese highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-3445-92025-02-04C16284748780-12cef2736-ae54-d83d-e063-dadaa90ab31fThese highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-3445-32025-01-30C16284748780-12cef2736-ae54-d83d-e063-dadaa90ab31fThese highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
68071-3445-92025-01-30C16284748780-12cef2736-ae54-d83d-e063-dadaa90ab31fThese highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68071-3445-3GABAPENTIN30 in 1 BOTTLETABLET303
68071-3445-9GABAPENTIN90 in 1 BOTTLETABLET903

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68071-3445GABAPENTIN TABLET [NUCARE PHARMACEUTICALS,INC.]3Current NDC, 2 package rows20250206_febf610e-e088-4797-e053-6294a90a3eb5.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310433gabapentin 600 MG Oral TabletPSNfebf610e-e088-4797-e053-6294a90a3eb53
310433gabapentin 600 MG Oral TabletSCDfebf610e-e088-4797-e053-6294a90a3eb53

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
68071-3445-36807134450330 TABLET in 1 BOTTLE (68071-3445-3) 30 tablet2023-06-22NoNoCurrent
68071-3445-96807134450990 TABLET in 1 BOTTLE (68071-3445-9) 90 tablet2023-06-22NoNoCurrent